- FDA plan to reduce antibiotic use in meat is a major step
The U.S. Food and Drug Administration’s decision on Wednesday to encourage reductions in the use of antibiotics in livestock production is a very big deal.
- Dengue fever is back: why the dangerous disease is here to stay
If the most efficient dengue fever carrier, a mosquito called Aedes aegypti, establishes itself in California, it won’t be because the state didn’t put up a fight.
- CRISPRs – Clustered Regularly Interspaced Short Palindromic Repeats
Around ten years ago we realised that the the natural world is a soup of bacteriophages. So how do bacteria survive against this constant onslaught?
- Global resistance to TB drugs is a ticking time bomb
The World Health Organization estimates almost 500,000 people around the world have a type of TB which is resistant to at least two of the main types of drugs used to treat the disease.
- How Mandela Wore a T-shirt in 2002 and Saved Millions of Lives
Nelson Mandela shocked the world in 2005 when he announced that his only surviving son, Makgatho Mandela, had died of AIDS.
- Hopes of HIV cure dashed
When trials of bone-marrow transplants were touted as an HIV cure a few months ago I was sceptical. Sadly, that seems to have been an appropriate response. HIV has reappeared in two of these patients who had seemed to be free of the virus for several months. They weren’t really free of the virus at all, it was just hiding at undetectable levels.
- FDA approves new $1,000-a-day hepatitis C pills
The U.S. The Food and Drug Administration has just approved a new drug that promises to treat hepatitis C with a daily pill instead of the more common weekly injection.